- Investing Ideas
- /
- French Pharmaceuticals & Biotech Potentially Undervalued Companies
French Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
14
0 new
Companies with a Value score of at least 3, ordered by Value score
14 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
IPN | €107.90 | -1.0% | 1.2% | €8.9b | €129.50 | PE13.4x | E6.9% | 1.1% | ||
VIRP | €312.00 | -3.6% | -11.7% | €2.6b | €402.94 | PE18.5x | E10.8% | 0.4% | ||
ALONC | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | ||
VLA | €2.00 | 8.9% | -55.9% | €325.4m | €6.83 | PS2.1x | E4.6% | n/a | ||
EAPI | €2.80 | -10.7% | -49.6% | €266.9m | €3.38 | PS0.3x | E69.2% | n/a | ||
OSE | €7.11 | -13.4% | 73.4% | €154.7m | €12.64 | PE3.4x | E-72.5% | n/a | ||
SAN | €91.50 | 0.9% | 2.9% | €114.7b | €113.80 | PE25.5x | E16.8% | 4.1% | ||
ALTHX | €0.59 | 21.0% | -45.6% | €4.6m | €6.20 | PS2x | E112.8% | n/a | ||
VETO | €77.00 | 0% | -24.4% | €911.1m | €96.57 | PE19.3x | E8.9% | 1.1% | ||
ERF | €47.68 | -1.1% | -19.1% | €9.0b | €59.46 | PE27.7x | E18.4% | 1.0% | ||
NANO | €3.30 | 0.4% | -40.0% | €156.5m | €11.70 | PS3.7x | E16.2% | n/a | ||
BOI | €26.85 | 1.7% | -34.2% | €466.2m | €33.30 | PE19.7x | E26.2% | 5.0% | ||
MEDCL | €17.08 | 13.7% | 155.3% | €499.2m | €22.83 | PS37.8x | E115.4% | n/a | ||
GNFT | €3.50 | -2.1% | 3.1% | €174.5m | €9.45 | PE7.8x | E41.2% | n/a |
Page 1 of 1